Affordable Access

deepdyve-link
Publisher Website

Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.

Authors
  • Sheridan, David A
  • Bridge, Simon H
  • Crossey, Mary M E
  • Felmlee, Daniel J
  • Fenwick, Fiona I
  • Thomas, Howard C
  • Neely, R Dermot G
  • Taylor-Robinson, Simon D
  • Bassendine, Margaret F
Type
Published Article
Journal
Liver international : official journal of the International Association for the Study of the Liver
Publication Date
May 01, 2014
Volume
34
Issue
5
Pages
737–747
Identifiers
DOI: 10.1111/liv.12316
PMID: 24118830
Source
Medline
Keywords
License
Unknown

Abstract

Fluvastatin and n-3 PUFAs have no effect on plasma HCV-RNA or LVP. The effect of low-dose n-3 PUFA on IP10 warrants further prospective evaluation as a supplemental therapy to enhance interferon sensitivity.

Report this publication

Statistics

Seen <100 times